{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:47:07Z","timestamp":1792788427339,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Municipal Health Commission\u201cProject of Science and Technology Innovation Center\u201d","award":["(PXM2019_026272_000006)( PXM2019_026272_000005)"],"award-info":[{"award-number":["(PXM2019_026272_000006)( PXM2019_026272_000005)"]}],"id":[{"id":"https:\/\/ror.org\/0374a5s68","id-type":"ROR","asserted-by":"crossref"}]},{"name":"This work were supported by the grant from National Key Research and Development Program of China","award":["(2017YFC0908800)"],"award-info":[{"award-number":["(2017YFC0908800)"]}]},{"name":"Beijing Municipal Administration of Hospitals\u2019 Ascent Planand Mission plan","award":["(DFL20150601) and (SML20180601)"],"award-info":[{"award-number":["(DFL20150601) and (SML20180601)"]}],"id":[{"id":"https:\/\/ror.org\/04baakq55","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accumulating evidence has underscored that coronary plaque morphology is the key determinant of acute cardiovascular events. The high-sensitivity C-reactive protein-triglyceride-glucose index (CTI) has been shown to correlate strongly with cardiovascular events and mortality. However, no previous study has investigated the relationship between CTI and detailed plaque morphological features evaluated using in vivo optical coherence tomography (OCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cross-sectional study, 444 patients with coronary artery disease (CAD) who underwent OCT prior to percutaneous coronary intervention (PCI) were analyzed. The association between CTI and plaque morphology was examined employing multivariable logistic regression models. Stratified analyses according to clinical presentation (stable angina pectoris [SAP] vs. acute coronary syndrome [ACS]) and tests for interaction were further performed. Receiver operating characteristic (ROC) curve analysis was used to assess the discriminative ability of CTI for identifying vulnerable plaques.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study revealed that participants divided into CTI quartiles exhibited a steadily rising prevalence of macrophage accumulation and healed plaque. Compared with the low CTI groups (Q1 and Q2), the incidences of cholesterol crystals and multiple healed plaques (\u2265\u20092) were significantly higher in the high CTI groups (Q3 and Q4) (cholesterol crystals: 35.1% and 24.3% vs. 18.9% and 13.5%; multiple healed plaques: 18.9% vs. 12.6%). After accounting for the effects of different covariates, analyzing CTI as a continuous variable revealed a significant link to healed plaque (OR\u2009=\u20091.62, 95%CI:1.21\u20132.16,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001), cholesterol crystals (OR\u2009=\u20091.64, 95%CI:1.17\u20132.30,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004), macrophage accumulation (OR\u2009=\u20091.49, 95%CI:1.13\u20131.98,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005), and plaque rupture (OR\u2009=\u20091.54, 95%CI:1.07\u20132.21,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.019). The statistically significant association persisted when CTI was split into quartiles. Notably, stratified analyses revealed that these significant associations were only present in patients with ACS. The RCS analysis demonstrated a linear association between CTI and various lipid plaque-related parameters. The area under the ROC curve (AUC) demonstrated that CTI exhibited a stronger correlation with plaque vulnerability compared with other single factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with ACS, elevated CTI is linked to an increased risk of healed plaque and vulnerable plaques. There is a linear relationship between CTI and various lipid plaque-related parameters. As a single factor, CTI provides a superior discriminative capacity for vulnerable plaque.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13098-026-02227-8","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:47:09Z","timestamp":1783565229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between hs-CRP-triglyceride glucose index and coronary plaque morphology: insights from optical coherence tomography"],"prefix":"10.1186","volume":"18","author":[{"given":"Hongying","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"2227_CR1","doi-asserted-by":"publisher","first-page":"e808","DOI":"10.1016\/S2214-109X(25)00013-0","volume":"13","author":"X An","year":"2025","unstructured":"An X, Liu Z, Zhang L, Zhao J, Gu Q, Han W, Hu Y, Xue F, Zhang F, Wang S, Ouyang W, Yang Y, Fu R, Yang W, Leng SX, Liu J, Jiang J, Pan X. Co-occurrence patterns and related risk factors of ischaemic heart disease and ischaemic stroke across 203 countries and territories: a spatial correspondence and systematic analysis. Lancet Global Health. 2025;13:e808\u201319.","journal-title":"Lancet Global Health"},{"key":"2227_CR2","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The Global Burden of Cardiovascular Diseases and Risk. J Am Coll Cardiol. 2022;80:2361\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"2227_CR3","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, Elkind M, Evenson KR, Eze-Nliam C, Ferguson JF, Generoso G, Ho JE, Kalani R, Khan SS, Kissela BM, Knutson KL, Levine DA, Lewis TT, Liu J, Loop MS, Ma J, Mussolino ME, Navaneethan SD, Perak AM, Poudel R, Rezk-Hanna M, Roth GA, Schroeder EB, Shah SH, Thacker EL, VanWagner LB, Virani SS, Voecks JH, Wang NY, Yaffe K, Martin SS. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022;145:e153\u2013639.","journal-title":"Circulation"},{"key":"2227_CR4","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41569-022-00687-9","volume":"19","author":"M Araki","year":"2022","unstructured":"Araki M, Park SJ, Dauerman HL, Uemura S, Kim JS, Di Mario C, Johnson TW, Guagliumi G, Kastrati A, Joner M, Holm NR, Alfonso F, Wijns W, Adriaenssens T, Nef H, Rioufol G, Amabile N, Souteyrand G, Meneveau N, Gerbaud E, Opolski MP, Gonzalo N, Tearney GJ, Bouma B, Aguirre AD, Mintz GS, Stone GW, Bourantas CV, Raber L, Gili S, Mizuno K, Kimura S, Shinke T, Hong MK, Jang Y, Cho JM, Yan BP, Porto I, Niccoli G, Montone RA, Thondapu V, Papafaklis MI, Michalis LK, Reynolds H, Saw J, Libby P, Weisz G, Iannaccone M, Gori T, Toutouzas K, Yonetsu T, Minami Y, Takano M, Raffel OC, Kurihara O, Soeda T, Sugiyama T, Kim HO, Lee T, Higuma T, Nakajima A, Yamamoto E, Bryniarski KL, Di Vito L, Vergallo R, Fracassi F, Russo M, Seegers LM, McNulty I, Park S, Feldman M, Escaned J, Prati F, Arbustini E, Pinto FJ, Waksman R, Garcia-Garcia HM, Maehara A, Ali Z, Finn AV, Virmani R, Kini AS, Daemen J, Kume T, Hibi K, Tanaka A, Akasaka T, Kubo T, Yasuda S, Croce K, Granada JF, Lerman A, Prasad A, Regar E, Saito Y, Sankardas MA, Subban V, Weissman NJ, Chen Y, Yu B, Nicholls SJ, Barlis P, West N, Arbab-Zadeh A, Ye JC, Dijkstra J, Lee H, Narula J, Crea F, Nakamura S, Kakuta T, Fujimoto J, Fuster V, Jang IK. Optical coherence tomography in coronary atherosclerosis assessment and intervention. Nat Rev Cardiol. 2022;19:684\u2013703.","journal-title":"Nat Rev Cardiol"},{"key":"2227_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/HCO.0000000000000917","volume":"36","author":"D Andreini","year":"2021","unstructured":"Andreini D, Conte E, Serruys PW. Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events. Curr Opin Cardiol. 2021;36:784\u201392.","journal-title":"Curr Opin Cardiol"},{"key":"2227_CR6","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","volume":"141","author":"MC Williams","year":"2020","unstructured":"Williams MC, Kwiecinski J, Doris M, McElhinney P, D\u2019Souza MS, Cadet S, Adamson PD, Moss AJ, Alam S, Hunter A, Shah A, Mills NL, Pawade T, Wang C, Weir MJ, Bonnici-Mallia M, Murrills C, Roditi G, van Beek E, Shaw LJ, Nicol ED, Berman DS, Slomka PJ, Newby DE, Dweck MR, Dey D. Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART). Circulation. 2020;141:1452\u201362.","journal-title":"Circulation"},{"key":"2227_CR7","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jcmg.2019.06.019","volume":"13","author":"D Andreini","year":"2020","unstructured":"Andreini D, Magnoni M, Conte E, Masson S, Mushtaq S, Berti S, Canestrari M, Casolo G, Gabrielli D, Latini R, Marraccini P, Moccetti T, Modena MG, Pontone G, Gorini M, Maggioni AP, Maseri A. Coronary Plaque Features on CTA Can Identify Patients at Increased Risk of Cardiovascular Events. Jacc Cardiovasc Imaging. 2020;13:1704\u201317.","journal-title":"Jacc Cardiovasc Imaging"},{"key":"2227_CR8","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1056\/NEJMra2000317","volume":"383","author":"R Vergallo","year":"2020","unstructured":"Vergallo R, Crea F. Atherosclerotic Plaque Healing. N Engl J Med. 2020;383:846\u201357.","journal-title":"N Engl J Med"},{"key":"2227_CR9","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/01.CIR.103.7.934","volume":"103","author":"AP Burke","year":"2001","unstructured":"Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation. 2001;103:934\u201340.","journal-title":"Circulation"},{"key":"2227_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/hrt.82.3.265","volume":"82","author":"J Mann","year":"1999","unstructured":"Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart. 1999;82:265\u20138.","journal-title":"Heart"},{"key":"2227_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132610","volume":"418","author":"C Deng","year":"2025","unstructured":"Deng C, Liu Z, Li C, Xu G, Zhang R, Bai Z, et al. Predictive models for cholesterol crystals and plaque vulnerability in acute myocardial infarction: insights from an optical coherence tomography study. Int J Cardiol. 2025;418:132610.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2227_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12933-024-02532-4","volume":"23","author":"S Wu","year":"2024","unstructured":"Wu S, Gao Y, Liu W, Wang R, Ma Q, Sun J, et al. The relationship between atherogenic index of plasma and plaque vulnerabilities: an optical coherence tomography study. Cardiovasc Diabetol. 2024;23:442.","journal-title":"Cardiovasc Diabetol"},{"key":"2227_CR13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jacc.2021.06.050","volume":"78","author":"AD Aguirre","year":"2021","unstructured":"Aguirre AD, Arbab-Zadeh A, Soeda T, Fuster V, Jang IK. Optical coherence tomography of plaque vulnerability and rupture: JACC focus seminar part 1\/3. J Am Coll Cardiol. 2021;78:1257\u201365.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2227_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12933-018-0692-1","volume":"17","author":"SB Lee","year":"2018","unstructured":"Lee SB, Ahn CW, Lee BK, Kang S, Nam JS, You JH, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 2018;17:41.","journal-title":"Cardiovasc Diabetol"},{"key":"2227_CR15","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/ijcp.12124","volume":"67","author":"C Irace","year":"2013","unstructured":"Irace C, Carallo C, Scavelli FB, De Franceschi MS, Esposito T, Tripolino C, et al. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract. 2013;67:665\u201372.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"2227_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12933-017-0589-4","volume":"16","author":"MK Kim","year":"2017","unstructured":"Kim MK, Ahn CW, Kang S, Nam JS, Kim KR, Park JS. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovasc Diabetol. 2017;16:108.","journal-title":"Cardiovasc Diabetol"},{"key":"2227_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jcct.2024.10.013","volume":"19","author":"YJ Choi","year":"2025","unstructured":"Choi YJ, Yang S, West H, Tomlins P, Hoshino M, Murai T, Hwang D, Shin ES, Doh JH, Nam CW, Wang J, Matsuo H, Kakuta T, Antoniades C, Koo BK. Association of coronary inflammation with plaque vulnerability and fractional flow reserve in coronary artery disease. J Cardiovasc Comput Tomogr. 2025;19:32\u20139.","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2227_CR18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jcmg.2024.07.013","volume":"17","author":"D Fujimoto","year":"2024","unstructured":"Fujimoto D, Kinoshita D, Suzuki K, Niida T, Yuki H, McNulty I, et al. Relationship Between Calcified Plaque Burden, Vascular Inflammation, and Plaque Vulnerability in Patients With Coronary Atherosclerosis. JACC Cardiovasc Imaging. 2024;17:1214\u201324.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2227_CR19","doi-asserted-by":"publisher","first-page":"e14959","DOI":"10.1161\/CIRCIMAGING.122.014959","volume":"16","author":"H Yuki","year":"2023","unstructured":"Yuki H, Sugiyama T, Suzuki K, Kinoshita D, Niida T, Nakajima A, Araki M, Dey D, Lee H, McNulty I, Nakamura S, Kakuta T, Jang IK. Coronary Inflammation and Plaque Vulnerability: A Coronary Computed Tomography and Optical Coherence Tomography Study. Circ Cardiovasc Imaging. 2023;16:e14959.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2227_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/joim.12406","volume":"278","author":"GK Hansson","year":"2015","unstructured":"Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med. 2015;278:483\u201393.","journal-title":"J Intern Med"},{"key":"2227_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jcmg.2023.08.019","volume":"17","author":"S Bienstock","year":"2024","unstructured":"Bienstock S, Lee SE, Lin F, Blankstein R, Leipsic J, Patel K, et al. Systemic Inflammation With High-Sensitivity C-Reactive Protein and Atherosclerotic Plaque Progression. JACC Cardiovasc Imaging. 2024;17:212\u20133.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2227_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132924","volume":"421","author":"M Katamine","year":"2025","unstructured":"Katamine M, Minami Y, Nagata T, Asakura K, Muramatsu Y, Kinoshita D, et al. High-sensitivity C-reactive protein, plaque vulnerability and adverse events in patients with stable coronary disease: An optical coherence tomography study. Int J Cardiol. 2025;421:132924.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2227_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12933-025-02629-4","volume":"24","author":"A Ramezankhani","year":"2025","unstructured":"Ramezankhani A, Tohidi M, Hadaegh F. Association between the systemic immune-inflammation index and metabolic syndrome and its components: results from the multi-ethnic study of atherosclerosis (MESA). Cardiovasc Diabetol. 2025;24:78.","journal-title":"Cardiovasc Diabetol"},{"key":"2227_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12933-025-02848-9","volume":"24","author":"H Ou","year":"2025","unstructured":"Ou H, Wei M, Li X, Xia X. C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0\u20133 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24:296.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2227_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-025-02835-0","volume":"24","author":"Y Sun","year":"2025","unstructured":"Sun Y, Guo Y, Ma S, Mao Z, Meng D, Xuan K, et al. Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study. Cardiovasc Diabetol. 2025;24:313.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2227_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12933-025-02876-5","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, Jia W, Guo J, Yang H, Sheng X, Wei L, et al. Association between the C-reactive protein-triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals. Cardiovasc Diabetol. 2025;24:316.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2227_CR27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12933-025-02960-w","volume":"24","author":"L Zhang","year":"2025","unstructured":"Zhang L, Li S, Liu D, Gui J, Hu J, Wang Q, et al. The relationship between C-reactive protein-triglyceride-glucose index and cardiovascular disease: insights from the China health and retirement longitudinal study (CHARLS). Cardiovasc Diabetol. 2025;24:410.","journal-title":"Cardiovasc Diabetol"},{"key":"2227_CR28","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138:e618\u201351.","journal-title":"Circulation"},{"key":"2227_CR29","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2020","unstructured":"Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020;42:1289\u2013367.","journal-title":"Eur Heart J"},{"key":"2227_CR30","doi-asserted-by":"publisher","first-page":"l5310","DOI":"10.1136\/bmj.l5310","volume":"367","author":"RJ Boffa","year":"2019","unstructured":"Boffa RJ, Constanti M, Floyd CN, Wierzbicki AS. Hypertension in adults: summary of updated NICE guidance. BMJ. 2019;367:l5310.","journal-title":"BMJ"},{"key":"2227_CR31","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, On BOTA. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46:S19\u201340.","journal-title":"Diabetes Care"},{"key":"2227_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5603\/CJ.a2021.0001","volume":"28","author":"C Borghi","year":"2021","unstructured":"Borghi C, Domienik-Karlowicz J, Tykarski A, Widecka K, Filipiak KJ, Jaguszewski MJ, Narkiewicz K, Mancia G. Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update. Cardiol J. 2021;28:1\u201314.","journal-title":"Cardiol J"},{"key":"2227_CR33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/01.CIR.78.2.486","volume":"78","author":"TJ Ryan","year":"1988","unstructured":"Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SR, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WJ, Et A. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology\/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1988;78:486\u2013502.","journal-title":"Circulation"},{"key":"2227_CR34","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","volume":"59","author":"GJ Tearney","year":"2012","unstructured":"Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012;59:1058\u201372.","journal-title":"J Am Coll Cardiol"},{"key":"2227_CR35","doi-asserted-by":"publisher","first-page":"118532","DOI":"10.1016\/j.atherosclerosis.2024.118532","volume":"396","author":"JM Kraaijenhof","year":"2024","unstructured":"Kraaijenhof JM, Mol BM, Nurmohamed NS, Dzobo KE, Kroon J, Hovingh GK, Mokry M, de Borst GJ, Stroes E, de Kleijn D. Plasma C-reactive protein is associated with a pro-inflammatory and adverse plaque phenotype. Atherosclerosis. 2024;396:118532.","journal-title":"Atherosclerosis"},{"key":"2227_CR36","doi-asserted-by":"publisher","first-page":"12171","DOI":"10.1038\/s41598-023-39051-3","volume":"13","author":"S Cederstrom","year":"2023","unstructured":"Cederstrom S, Lundman P, Alfredsson J, Hagstrom E, Ravn-Fischer A, Soderberg S, Yndigegn T, Tornvall P, Jernberg T. Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population. Sci Rep. 2023;13:12171.","journal-title":"Sci Rep"},{"key":"2227_CR37","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","volume":"379","author":"DI Swerdlow","year":"2012","unstructured":"Swerdlow DI, Holmes MV, Kuchenbaecker KB, Engmann JE, Shah T, Sofat R, Guo Y, Chung C, Peasey A, Pfister R, Mooijaart SP, Ireland HA, Leusink M, Langenberg C, Li KW, Palmen J, Howard P, Cooper JA, Drenos F, Hardy J, Nalls MA, Li YR, Lowe G, Stewart M, Bielinski SJ, Peto J, Timpson NJ, Gallacher J, Dunlop M, Houlston R, Tomlinson I, Tzoulaki I, Luan J, Boer JM, Forouhi NG, Onland-Moret NC, van der Schouw YT, Schnabel RB, Hubacek JA, Kubinova R, Baceviciene M, Tamosiunas A, Pajak A, Topor-Madry R, Malyutina S, Baldassarre D, Sennblad B, Tremoli E, de Faire U, Ferrucci L, Bandenelli S, Tanaka T, Meschia JF, Singleton A, Navis G, Mateo LI, Bakker SJ, Gansevoort RT, Ford I, Epstein SE, Burnett MS, Devaney JM, Jukema JW, Westendorp RG, Jan DBG, van der Graaf Y, de Jong PA, Mailand-van DZA, Klungel OH, de Boer A, Doevendans PA, Stephens JW, Eaton CB, Robinson JG, Manson JE, Fowkes FG, Frayling TM, Price JF, Whincup PH, Morris RW, Lawlor DA, Smith GD, Ben-Shlomo Y, Redline S, Lange LA, Kumari M, Wareham NJ, Verschuren WM, Benjamin EJ, Whittaker JC, Hamsten A, Dudbridge F, Delaney JA, Wong A, Kuh D, Hardy R, Castillo BA, Connolly JJ, van der Harst P, Brunner EJ, Marmot MG, Wassel CL, Humphries SE, Talmud PJ, Kivimaki M, Asselbergs FW, Voevoda M, Bobak M, Pikhart H, Wilson JG, Hakonarson H, Reiner AP, Keating BJ, Sattar N, Hingorani AD, Casas JP. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012;379:1214\u201324.","journal-title":"Lancet"},{"key":"2227_CR38","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","volume":"379","author":"N Sarwar","year":"2012","unstructured":"Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P, Gorman DN, Gao P, Saleheen D, Rendon A, Nelson CP, Braund PS, Hall AS, Chasman DI, Tybjaerg-Hansen A, Chambers JC, Benjamin EJ, Franks PW, Clarke R, Wilde AA, Trip MD, Steri M, Witteman JC, Qi L, van der Schoot CE, de Faire U, Erdmann J, Stringham HM, Koenig W, Rader DJ, Melzer D, Reich D, Psaty BM, Kleber ME, Panagiotakos DB, Willeit J, Wennberg P, Woodward M, Adamovic S, Rimm EB, Meade TW, Gillum RF, Shaffer JA, Hofman A, Onat A, Sundstrom J, Wassertheil-Smoller S, Mellstrom D, Gallacher J, Cushman M, Tracy RP, Kauhanen J, Karlsson M, Salonen JT, Wilhelmsen L, Amouyel P, Cantin B, Best LG, Ben-Shlomo Y, Manson JE, Davey-Smith G, de Bakker PI, O\u2019Donnell CJ, Wilson JF, Wilson AG, Assimes TL, Jansson JO, Ohlsson C, Tivesten A, Ljunggren O, Reilly MP, Hamsten A, Ingelsson E, Cambien F, Hung J, Thomas GN, Boehnke M, Schunkert H, Asselbergs FW, Kastelein JJ, Gudnason V, Salomaa V, Harris TB, Kooner JS, Allin KH, Nordestgaard BG, Hopewell JC, Goodall AH, Ridker PM, Holm H, Watkins H, Ouwehand WH, Samani NJ, Kaptoge S, Di Angelantonio E, Harari O, Danesh J. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012;379:1205\u201313.","journal-title":"Lancet"},{"key":"2227_CR39","doi-asserted-by":"publisher","first-page":"d548","DOI":"10.1136\/bmj.d548","volume":"342","author":"F Wensley","year":"2011","unstructured":"Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T, Engert JC, Clarke R, Davey-Smith G, Nordestgaard BG, Saleheen D, Samani NJ, Sandhu M, Anand S, Pepys MB, Smeeth L, Whittaker J, Casas JP, Thompson SG, Hingorani AD, Danesh J. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ. 2011;342:d548.","journal-title":"BMJ"},{"key":"2227_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mendia","year":"2008","unstructured":"Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"key":"2227_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/eci.12583","volume":"46","author":"L Sanchez-Inigo","year":"2016","unstructured":"Sanchez-Inigo L, Navarro-Gonzalez D, Fernandez-Montero A, Pastrana-Delgado J, Martinez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46:189\u201397.","journal-title":"Eur J Clin Invest"},{"key":"2227_CR42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12944-018-0914-2","volume":"17","author":"KB Won","year":"2018","unstructured":"Won KB, Park GM, Lee SE, Cho IJ, Kim HC, Lee BK, Chang HJ. Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness. Lipids Health Dis. 2018;17:268.","journal-title":"Lipids Health Dis"},{"key":"2227_CR43","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1038\/s41598-019-42700-1","volume":"9","author":"YR Cho","year":"2019","unstructured":"Cho YR, Ann SH, Won KB, Park GM, Kim YG, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee SW, Kim YH, Kim SJ, Lee SG. Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes. Sci Rep. 2019;9:6129.","journal-title":"Sci Rep"},{"key":"2227_CR44","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jcin.2025.04.044","volume":"18","author":"FG Biccire","year":"2025","unstructured":"Biccire FG, Fabbiocchi F, Gatto L, La Manna A, Ozaki Y, Romagnoli E, Marco V, Boi A, Fineschi M, Piedimonte G, Cerrato E, Musto C, Taglieri N, Di Giorgio A, Vizzari G, Ruscica G, Canova PA, Vergallo R, Burzotta F, Limbruno U, Albertucci M, Raber L, Crea F, Alfonso F, Arbustini E, Stone GW, Prati F. Long-Term Prognostic Impact of OCT-Derived High-Risk Plaque Features: Extended Follow-Up of the CLIMA Study. Jacc Cardiovasc Interv. 2025;18:1361\u201372.","journal-title":"Jacc Cardiovasc Interv"},{"key":"2227_CR45","doi-asserted-by":"publisher","first-page":"e707","DOI":"10.4244\/EIJ-D-23-00628","volume":"20","author":"VD Del","year":"2024","unstructured":"Del VD, Berta B, Roleder T, Malinowski K, Bastante T, Hermanides RS, Wojakowski W, Fabris E, Cuesta J, De Luca G, Rivero F, Alfonso F, Kedhi E. Vulnerable plaque features and adverse events in patients with diabetes mellitus: a post hoc analysis of the COMBINE OCT-FFR trial. Eurointervention. 2024;20:e707\u201317.","journal-title":"Eurointervention"},{"key":"2227_CR46","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.jacc.2018.10.093","volume":"73","author":"F Fracassi","year":"2019","unstructured":"Fracassi F, Crea F, Sugiyama T, Yamamoto E, Uemura S, Vergallo R, Porto I, Lee H, Fujimoto J, Fuster V, Jang IK. Healed Culprit Plaques in Patients With Acute Coronary Syndromes. J Am Coll Cardiol. 2019;73:2253\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"2227_CR47","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/ehjci\/jez308","volume":"21","author":"M Russo","year":"2020","unstructured":"Russo M, Kim HO, Kurihara O, Araki M, Shinohara H, Thondapu V, Yonetsu T, Soeda T, Minami Y, Higuma T, Lee H, Fracassi F, Vergallo R, Niccoli G, Crea F, Fuster V, Jang IK. Characteristics of non-culprit plaques in acute coronary syndrome patients with layered culprit plaque. Eur Heart J Cardiovasc Imaging. 2020;21:1421\u201330.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2227_CR48","doi-asserted-by":"publisher","first-page":"119092","DOI":"10.1016\/j.atherosclerosis.2024.119092","volume":"401","author":"B Yi","year":"2025","unstructured":"Yi B, He L, Zhang D, Zeng M, Zhao C, Meng W, Qin Y, Weng Z, Xu Y, Liu M, Chen X, Shao S, Sun Q, Wang W, Li M, Lv Y, Luo X, Bai X, Weng X, Johnson JL, Johnson T, Guagliumi G, Hu S, Yu B, Jia H. Non-culprit plaque healing on serial OCT imaging and future outcome in patients with acute coronary syndromes. Atherosclerosis. 2025;401:119092.","journal-title":"Atherosclerosis"},{"key":"2227_CR49","doi-asserted-by":"publisher","first-page":"e9125","DOI":"10.1161\/CIRCINTERVENTIONS.120.009125","volume":"13","author":"J Dai","year":"2020","unstructured":"Dai J, Fang C, Zhang S, Li L, Wang Y, Xing L, Yu H, Jiang S, Yin Y, Wang J, Wang Y, Guo J, Lei F, Liu H, Xu M, Ren X, Ma L, Wei G, Zhang S, Hou J, Mintz GS, Yu B, Frequency. Predictors, Distribution, and Morphological Characteristics of Layered Culprit and Nonculprit Plaques of Patients With Acute Myocardial Infarction: In Vivo 3-Vessel Optical Coherence Tomography Study. Circ Cardiovasc Interv. 2020;13:e9125.","journal-title":"Circ Cardiovasc Interv"},{"key":"2227_CR50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jacc.2022.11.013","volume":"81","author":"PB Duell","year":"2023","unstructured":"Duell PB. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease Risk. J Am Coll Cardiol. 2023;81:153\u20135.","journal-title":"J Am Coll Cardiol"},{"key":"2227_CR51","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","volume":"42","author":"HN Ginsberg","year":"2021","unstructured":"Ginsberg HN, Packard CJ, Chapman MJ, Boren J, Aguilar-Salinas CA, Averna M, Ference BA, Gaudet D, Hegele RA, Kersten S, Lewis GF, Lichtenstein AH, Moulin P, Nordestgaard BG, Remaley AT, Staels B, Stroes E, Taskinen MR, Tokgozoglu LS, Tybjaerg-Hansen A, Stock JK, Catapano AL. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42:4791\u2013806.","journal-title":"Eur Heart J"},{"key":"2227_CR52","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","volume":"14","author":"KE Bornfeldt","year":"2011","unstructured":"Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14:575\u201385.","journal-title":"Cell Metab"},{"key":"2227_CR53","first-page":"2525","volume":"117","author":"P Libby","year":"2021","unstructured":"Libby P. Inflammation during the life cycle of the atherosclerotic plaque. Cardiovasc Res. 2021;117:2525\u201336.","journal-title":"Cardiovasc Res"},{"key":"2227_CR54","doi-asserted-by":"crossref","unstructured":"Rat N, Botond-Barna M, Bajka B, Corneliu-Florin Buicu, Theodora Benedek, Imre Benedek. Highly inflamed coronary plaque detected by Angio-CT in a 28-year-old patient with STEMI and long COVID-19. IMAGING. 2024;16(2):113\u2013117.","DOI":"10.1556\/1647.2024.00195"},{"key":"2227_CR55","doi-asserted-by":"publisher","first-page":"1511319","DOI":"10.3389\/fendo.2025.1511319","volume":"16","author":"B Wan","year":"2025","unstructured":"Wan B, Wang S, Hu S, Han W, Qiu S, Zhu L, Ruan L, Wei Y, Xu J. The comprehensive effects of high-sensitivity C-reactive protein and triglyceride glucose index on cardiometabolic multimorbidity. Front Endocrinol. 2025;16:1511319.","journal-title":"Front Endocrinol"},{"key":"2227_CR56","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s00125-010-1865-y","volume":"53","author":"VB Matthews","year":"2010","unstructured":"Matthews VB, Allen TL, Risis S, Chan MHS, Henstridge DC, Watson N, Zaffino LA, Babb JR, Boon J, Meikle PJ, Jowett JB, Watt MJ, Jansson J, Bruce CR, Febbraio MA. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia. 2010;53:2431\u201341.","journal-title":"Diabetologia"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02227-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02227-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02227-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:02:06Z","timestamp":1790946126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02227-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2227"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02227-8","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics Committee of the Beijing Anzhen Hospital, Capital Medical University approved the study protocol(Approval No. 2026166X). As the data were obtained retrospectively from EMR, the review board waived the need for written informed consent from the patients.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"211"}}